DANIEL LEWIS SPITZ M.D. NPI 1134125214

NPI Details

Daniel Lewis Spitz, M.D. is a medical oncology internal medicine in West Palm Beach, FL with 45 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Daniel Lewis Spitz, M.D. NPI is 1134125214. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE
Graduation Year:1980

The provider's business location address is:

1309 N FLAGLER DR
FLORIDA CANCER SPECIALISTS
WEST PALM BEACH, FL
ZIP 33401-406
Phone: (561) 366-4100
Fax: (561) 366-4189

The NPI 1134125214 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Iron level (HCPCS:83540)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Ferritin (blood protein) level (HCPCS:82728)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Iron binding capacity (HCPCS:83550)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Folic acid level, serum (HCPCS:82746)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Protein measurement, serum (HCPCS:84165)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Magnesium level (HCPCS:83735)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Ct scan of chest with contrast (HCPCS:71260)
• Vitamin d-3 level (HCPCS:82306)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Drawing of blood for a medical problem (HCPCS:99195)
• Automated urinalysis test (HCPCS:81003)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Injection of drug or substance into vein (HCPCS:96374)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Red blood count automated, with additional calculations (HCPCS:85046)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Ct scan of chest without contrast (HCPCS:71250)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Hemoglobin a1c level (HCPCS:83036)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)

The enumeration date for this NPI number is 6/23/2005 and was last updated on 9/2/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.